PRINSTON INC FDA Approval ANDA 040580

ANDA 040580

PRINSTON INC

FDA Drug Application

Application #040580

Application Sponsors

ANDA 040580PRINSTON INC

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET;ORAL50MG0HYDROXYZINE HYDROCHLORIDEHYDROXYZINE HYDROCHLORIDE
002TABLET;ORAL25MG0HYDROXYZINE HYDROCHLORIDEHYDROXYZINE HYDROCHLORIDE
003TABLET;ORAL10MG0HYDROXYZINE HYDROCHLORIDEHYDROXYZINE HYDROCHLORIDE

FDA Submissions

ORIG1AP2005-05-27
LABELING; LabelingSUPPL5AP2013-04-30STANDARD
LABELING; LabelingSUPPL8AP2014-06-04STANDARD
LABELING; LabelingSUPPL11AP2016-03-30STANDARD
LABELING; LabelingSUPPL14AP2016-11-08STANDARD

Submissions Property Types

SUPPL5Null15
SUPPL8Null15
SUPPL11Null7
SUPPL14Null15

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

PRINSTON INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 40580
            [companyName] => PRINSTON INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYDROXYZINE HYDROCHLORIDE","activeIngredients":"HYDROXYZINE HYDROCHLORIDE","strength":"50MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"HYDROXYZINE HYDROCHLORIDE","submission":"HYDROXYZINE HYDROCHLORIDE","actionType":"50MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.